Back
Marinus Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
MRNS
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
34
MRNS
Marinus Pharmaceuticals
Last Price:
1.49
Seasonality Move:
-0.7%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" projectMarinus Pharmaceuticals Price Quote
$1.49
-0.02 (-1.32%)
(Updated: May 6, 2024 at 6:55 PM ET)
Marinus Pharmaceuticals Key Stats
Sell
34
Marinus Pharmaceuticals (MRNS)
is a Sell
Day range:
$1.48 - $1.65
52-week range:
$1.11 - $11.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.62
P/B ratio:
4.95%
Volume:
1.6M
Avg. volume:
3.4M
1-year change:
-83.22%
Market cap:
$82.9M
Revenue:
$31M
EPS:
$-2.63
How Much Does Marinus Pharmaceuticals Make?
-
How Much Are Marinus Pharmaceuticals's Sales Annually?
MRNS Revenues are $31M -
How Much Profit Does Marinus Pharmaceuticals's Make A Year?
MRNS net income is -$141.4M
Is Marinus Pharmaceuticals Growing As A Company?
-
What Is Marinus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Marinus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Marinus Pharmaceuticals Stock Price Performance
-
Did Marinus Pharmaceuticals Stock Go Up Last Month?
Marinus Pharmaceuticals share price went down by -82.64% last month -
Did MRNS's Share Price Rise Over The Last Year?
MRNS share price fell by -83.22% over the past 1 year
What Is Marinus Pharmaceuticals 52-Week High & Low?
-
What Is Marinus Pharmaceuticals’s 52-Week High Share Price?
Marinus Pharmaceuticals has traded as high as $11.26 over the past 52 weeks -
What Is Marinus Pharmaceuticals’s 52-Week Low Share Price?
Marinus Pharmaceuticals has traded as low as $1.11 over the past 52 weeks
Marinus Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Marinus Pharmaceuticals?
-
How Much Debt Does Marinus Pharmaceuticals Have?
Total long term debt quarterly is $73M -
How Much Cash Does Marinus Pharmaceuticals Have?
Cash and short term investments quarterly total is $150.3M -
What Is Marinus Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.31
Is Marinus Pharmaceuticals Cash Flow Positive?
-
What Is MRNS Cash Flow From Operations?
Cash flow from operations (TTM) is -$118M -
What Is Marinus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.6M -
What Is Marinus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$28.6M
Marinus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MRNS return on invested capital is -102.32% -
What Is Marinus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -66.75% -
What Is MRNS Return On Equity?
ROE is a measure of profitability and is -214.43%
Marinus Pharmaceuticals Earnings Date & Stock Price
-
What Is Marinus Pharmaceuticals's Stock Price Today?
A single share of MRNS can be purchased today for 1.51 -
What Is Marinus Pharmaceuticals’s Stock Symbol?
Marinus Pharmaceuticals trades on the nasdaq under the ticker symbol: MRNS -
When Is Marinus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Marinus Pharmaceuticals is scheduled on May 10, 2024 -
When Is MRNS's next ex-dividend date?
Marinus Pharmaceuticals's next ex-dividend date is May 6, 2024 -
How To Buy Marinus Pharmaceuticals Stock?
You can buy Marinus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Marinus Pharmaceuticals Competitors
-
Who Are Marinus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Marinus Pharmaceuticals or are related in some way:
Marinus Pharmaceuticals Dividend Yield
Data Unavailable
Marinus Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -30.23% |
Revenue: | 0.39% | -11.66% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 10.44 |
Upside from Last Price: | 591.68% |